Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine
OphthaTherapy. Therapies in Ophthalmology · 29.10.2025 · 12 (3) · 248-251
DOI: 10.24292/01.ot.001225 ↗Kurz gefasst
Fachartikel in der Zeitschrift OphthaTherapy. Therapies in Ophthalmology, online erschienen am 29.10.2025. Verfasst von Monika Udziela und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Red eye is a symptom which may indicated different disorders. Mild hyperemia may occur without any defined aetiology and may cause esthetical and psychological problems for the patients. Diagnostics is crucial before implementing the symptomatic treatment to exclude any disease requiring targeted therapy. All cases of red eye symptom with pain and visual disturbances require special attention. Eyedrops with low-dose brimonidine are good alternative to other vasoconstrictors, as safe and well-tolerated medication not leading to hypoxia, tachyphylaxis and rebound effect.
Zitieren
APA
Udziela, M., & Sapilak, B. (2025). Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine. OphthaTherapy. Therapies in Ophthalmology, 12(3), 248-251. https://doi.org/10.24292/01.ot.001225
Vancouver
Udziela M, Sapilak B. Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine. OphthaTherapy. Therapies in Ophthalmology. 2025;12(3):248-251. doi:10.24292/01.ot.001225
BibTeX
@article{Udziela2025,
author = {Udziela, Monika and Sapilak, Bartosz},
title = {Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine},
journal = {OphthaTherapy. Therapies in Ophthalmology},
year = {2025},
volume = {12},
number = {3},
pages = {248--251},
doi = {10.24292/01.ot.001225}
}
EUVIMED